Agilent Technologies Completes Acquisition of Advanced Analytical Technologies, Inc.

SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies, Inc. (NYSE: A) today announced that it has
completed the acquisition of Advanced Analytical Technologies, Inc.
(AATI), a provider of capillary electrophoresis-based (CE) solutions for
fully-automated analysis of a range of molecules for $250 million in

This acquisition brings together two innovators in the electrophoresis
space. Advances in genomics, metabolomics, and proteomics are driving
growth and demand for robust, purpose built solutions to analyze
biomolecules such as nucleic acids (RNA and DNA), proteins,
carbohydrates and small molecules. AATI has developed compelling
products based on CE technologies that provide key advances in
sensitivity and resolution to address a wide range of applications
across a variety of industry segments.

“We are pleased to announce that the transaction is now complete, and we
are looking forward to integrating the teams,” said Sam Raha, president
of Agilent’s Diagnostics and Genomics Group. “This acquisition enhances
Agilent’s existing expertise and technology base, and will allow us to
provide customers with a more comprehensive set of solutions for Next
Generation Sequencing (NGS) workflows and also for other applications.”

AATI’s 109 employees with join Agilent as part of the new Biomolecular
Analysis Division within its Diagnostics and Genomics Group. The new
Biomolecular Analysis Division will also consist of Agilent’s existing
microfluidics business, which was previously part of Agilent’s Life
Sciences and Applied Markets Group.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences,
diagnostics, and applied chemical markets. With more than 50 years of
insight and innovation, Agilent instruments, software, services,
solutions, and people provide trusted answers to its customers’ most
challenging questions. The company generated revenues of $4.47 billion
in fiscal 2017 and employs 14,200 people worldwide. Information about
Agilent is available at

Forward-Looking Statements

This news release contains forward-looking statements as defined in the
Securities Exchange Act of 1934 and is subject to the safe harbors
created therein. The forward-looking statements contained herein
include, but are not limited to, information regarding Agilent’s future
revenue, earnings and profitability; planned new products; market
trends; the future demand for the company’s products and services;
customer expectations; and revenue and non-GAAP earnings guidance for
the third quarter and full fiscal year 2018. These forward-looking
statements involve risks and uncertainties that could cause Agilent’s
results to differ materially from management’s current expectations.
Such risks and uncertainties include, but are not limited to, unforeseen
changes in the strength of our customers’ businesses; unforeseen changes
in the demand for current and new products, technologies, and services;
unforeseen changes in the currency markets; customer purchasing
decisions and timing, and the risk that we are not able to realize the
savings expected from integration and restructuring activities. In
addition, other risks that Agilent faces in running its operations
include the ability to execute successfully through business cycles; the
ability to meet and achieve the benefits of its cost-reduction goals and
otherwise successfully adapt its cost structures to continuing changes
in business conditions; ongoing competitive, pricing and gross-margin
pressures; the risk that our cost-cutting initiatives will impair our
ability to develop products and remain competitive and to operate
effectively; the impact of geopolitical uncertainties and global
economic conditions on our operations, our markets and our ability to
conduct business; the ability to improve asset performance to adapt to
changes in demand; the ability of our supply chain to adapt to changes
in demand; the ability to successfully introduce new products at the
right time, price and mix; the ability of Agilent to successfully
integrate recent acquisitions; the ability of Agilent to successfully
comply with certain complex regulations; and other risks detailed in
Agilent’s filings with the Securities and Exchange Commission, including
our quarterly report on Form 10-Q for the quarter ended April 30, 2018.
Forward-looking statements are based on the beliefs and assumptions of
Agilent’s management and on currently available information. Agilent
undertakes no responsibility to publicly update or revise any
forward-looking statement.

NOTE TO EDITORS: Further technology, corporate citizenship and executive
news is available on the Agilent news site at


Agilent Technologies:
Wadsworth-Hansen (Business), +1 408-553-2005
+ 45 29336980
Notaney (Enterprise), +1 408-345-8955
Alicia Rodriguez, +1 408-345-8948